What Breaking Bad Can Teach Us About Lung Cancer

Three words that start a series

Breaking Bad opens with a fictional chemistry teacher being told he has inoperable non-small cell lung cancer. Everything that follows depends on those words.

Walter White is a character, not a patient, and nothing here describes a real person. But the phrase he is handed is a real one, and each part of it carries specific meaning. Unpacking it is more useful than the plot.

What "non-small cell" is distinguishing

Lung cancers are sorted first by what the cells look like under a microscope. Non-small cell lung cancer is the larger group. Small cell lung cancer is the other, named for the appearance of its cells, and it behaves very differently.

The distinction is not cosmetic. Small cell disease grows and spreads quickly and is usually treated with chemotherapy and radiation rather than surgery. Non-small cell disease is slower and surgery is often on the table.

Non-small cell lung cancer includes adenocarcinoma, squamous cell carcinoma and large cell carcinoma. Our page on lung cancer sets out how they differ.

NCI is blunt about cause: smoking is the major risk factor. It is equally clear that people who never smoked also develop lung cancer. Both statements are true, and the second one is why symptoms in a non-smoker should never be dismissed. Our page on smoking, vaping and lung cancer risk covers the exposure side.

What makes a tumor inoperable

"Inoperable" is not a verdict about how serious the cancer is. It is a statement about geometry and fitness.

NCI puts it plainly: to plan treatment, it is important to know the stage of the disease and whether the cancer can be removed by surgery. Those are two separate questions asked at the same time.

A tumor may be unremovable because of where it sits, for instance wrapped around major blood vessels or the airway, or because it has spread to lymph nodes or organs that surgery cannot reach. Or the person's lungs and heart may not tolerate an operation, since removing lung tissue permanently reduces breathing capacity.

Staging tells you both. NCI's stages for non-small cell lung cancer start with occult disease, where cancer cells appear in sputum but nothing shows on imaging, then stage 0, where abnormal cells sit only in the lining of the airways. In stage IA the tumor is 3 cm or smaller, confined to the lung, with no lymph node involvement. In stage IB it is larger than 3 cm but no more than 4 cm, or 4 cm or smaller with spread into the main bronchus. Our page on cancer staging explains the general system.

The four lung operations

When surgery is possible, NCI describes four procedures, distinguished by how much lung is taken.

• Wedge resection removes the tumor with a margin of normal tissue around it. Taking slightly more is called a segmental resection.
• Lobectomy removes a whole lobe. The right lung has three; the left has two.
• Pneumonectomy removes an entire lung.
• Sleeve resection removes a section of the bronchus, the main airway, and rejoins the ends.

Chemotherapy or radiation may follow to kill cells left behind. Treatment given after surgery to lower the chance of return is called adjuvant therapy.

What exists when surgery does not

This is where the phrase "inoperable" has changed meaning most since 2008.

NCI lists nine types of treatment for non-small cell lung cancer: surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy, laser therapy, photodynamic therapy, cryosurgery and electrocautery.

Two of those barely existed as options for lung cancer when the series began. Targeted therapy attacks a specific change inside the tumor, and NCI now lists more than 25 such drugs for this disease, including osimertinib, alectinib, sotorasib and lorlatinib. Immunotherapy releases a brake on the immune system, with seven drugs listed including pembrolizumab, nivolumab and durvalumab.

Both depend on testing the tumor first. NCI notes that biomarker tests may be suggested to predict response to targeted and immunotherapy drugs. Without the test, the drug is a guess. Our page on biomarker testing covers what is looked for.

Radiation has changed too. Stereotactic body radiation therapy sends a precise high dose to a small target. It can treat some early tumors in people who cannot have surgery.

When to get checked

Screening applies to a defined group. The US Preventive Services Task Force recommends yearly low-dose CT for adults aged 50 to 80 with a 20 pack-year smoking history who currently smoke or quit within the past 15 years. Screening stops after 15 smoke-free years, or when another health problem would rule out surgery.

Outside that group, symptoms are the route. NCI notes lung cancer sometimes causes nothing at all and is found on a chest X-ray done for another reason. Check with a doctor about:

• Chest discomfort or pain.
• A cough that does not go away or gets worse.
• Trouble breathing, or wheezing.
• Blood in sputum, the mucus coughed up from the lungs.
• Hoarseness, or trouble swallowing.
• Loss of appetite, or weight loss with no known cause.
• Fatigue.
• Swelling in the face, or in the veins of the neck.

That last one is urgent. It can mean pressure on the large vein returning blood to the heart.

The wider numbers

The American Cancer Society projects about 229,410 new lung and bronchus cancers in the United States in 2026 and about 124,990 deaths, which is 20.0% of all cancer deaths; SEER reports those projections next to its own measurements. Five-year relative survival for 2016 to 2022 was 29.5%.

Stage drives it, again over that 2016–2022 group: 65.5% while the cancer is confined to the lung, 38.2% with regional nodes involved, 10.5% once distant. Only 24% are found at the first stage and 51% are already distant. Median age at diagnosis is 71. These are population figures across both main types and describe no individual.

What this does not mean

A drama is written to move a plot, not to model a treatment plan. A television diagnosis has no stage, no biomarker result and no lung function test behind it.

"Inoperable" does not mean untreatable, and it did not mean that in 2008 either. It means one tool is off the table.

And the numbers above are averages over a whole population and several years. They cannot be applied to a person, real or fictional.

Sources

• NCI PDQ, Non-Small Cell Lung Cancer Treatment (Patient Version) — https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq
• US Preventive Services Task Force, Lung Cancer: Screening — https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening
• SEER Cancer Stat Facts, Lung and Bronchus Cancer — https://seer.cancer.gov/statfacts/html/lungb.html

How this article was prepared

An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.

The National Cancer Information Foundation publishes Cancer Explained. This page is for learning. It is not medical advice and does not suggest a test or treatment.

See an error, old source, or unclear wording? Tell us.